Centre Hospitalier Universitaire Vaudois clinical trials
Centre Hospitalier Universitaire Vaudois is the lead sponsor of 36 current clinical trials in our Switzerland, Germany, Austria, Denmark, Italy and EU (CTIS) registers. 17 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Cyclophosphamide, Morphine administered at a scheduled and Morphine provided via PCA. The most-studied condition is Pancreatic Adenocarcinoma.
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by Centre Hospitalier Universitaire Vaudois
35 on ClinicalTrials.govRegisters list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Centre Hospitalier Universitaire Vaudois in the EU trials register (CTIS)
1 trialAuthorised or ongoing trials in the EU Clinical Trials Information System with Centre Hospitalier Universitaire Vaudois as sponsor. Some are the same study as a ClinicalTrials.gov record above; the two registries share no common ID. Trials with a site in Ireland are listed first.
| Study | Phase | Status | Countries |
|---|---|---|---|
|
HORUS-Cytomegalovirus Open Proof-of-concept Exploratory trial
2025-524845-28-00 · Virus Diseases
Drug: Everolimus |
Phase 4 | Authorised | France, Spain |
Drugs in Centre Hospitalier Universitaire Vaudois trials
12 compoundsDrugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.
Conditions in Centre Hospitalier Universitaire Vaudois trials
65 conditionsBy trial register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Switzerland | 34 | 17 |
| Clinical trials in Germany | 2 | 0 |
| Clinical trials in Austria | 2 | 0 |
| Clinical trials in Denmark | 1 | 0 |
| Clinical trials in Italy | 1 | 0 |
| EU register (CTIS) | 1 | — |
A trial with sites in more than one country appears in each of those registers.
Other sponsors in Pancreatic Adenocarcinoma
Sponsors with the most current trials registered for this condition.
Questions about Centre Hospitalier Universitaire Vaudois trials
How many clinical trials does Centre Hospitalier Universitaire Vaudois sponsor?
Centre Hospitalier Universitaire Vaudois is the lead sponsor of 35 current trials on ClinicalTrials.gov in our Switzerland, Germany, Austria, Denmark and Italy registers, and 1 authorised or ongoing trial in the EU register (CTIS), as of the registry sync on 14 November 2026. Completed and withdrawn studies are not counted.
Are Centre Hospitalier Universitaire Vaudois trials recruiting?
Yes. 17 of its 35 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Which drugs is Centre Hospitalier Universitaire Vaudois testing?
Its current trials name 12 drugs and biologicals as interventions. The most frequent are Cyclophosphamide (2), Morphine administered at a scheduled (2), Morphine provided via PCA (2), Aldesleukin (1) and Apixaban (1). The number in brackets is how many of its trials name each drug.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 14 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.